Effects of a Soya-Based Fibre Beverage on Weight and Health in Overweight Adults
SBB-WEIGHTLOSS
Research on the Effect of Soya-Based Dietary Fibre Beverages (SBB) in Improving Anthropometric Parameters and Biomarker Profiles Among Overweight Students and Staff in Health Campus, Universiti Sains Malaysia, Kelantan
2 other identifiers
interventional
42
1 country
1
Brief Summary
The goal of this intervention study is to evaluate the effect of soya-based dietary fiber beverage (SBB) in overweight adults. The main question it aims to answer is: Does the SBB effective in improving the weight and metabolic parameters among overweight adults? Overweight participants will be randomly assigned to intervention or control group for a defined intervention period. The intervention involved the consumption of the SBB beverage powder while allowing participants to maintain their usual meal portions. while the control group will be asked to continue their usual breakfast, lunch, and dinner meals during the study period. Clinical and biochemical parameters will be assessed at baseline and after the intervention period to evaluate potential metabolic changes. Anthropometric and body composition will be recorded. Assessments will include questionnaires related to food frequency (FFQ), food diary, physical activity (IPAQ), satiety and appetite, and defecation behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 15, 2026
CompletedFirst Posted
Study publicly available on registry
May 29, 2026
CompletedMay 29, 2026
May 1, 2026
5 months
May 15, 2026
May 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Change in weight (kg)
Changes in body weight (kg) from baseline to week 12
Baseline, week 4, week 8 and week 12
Change in body fat percentage (%)
Change in body fat percentage (%) from baseline to week 12.
Baseline, week 4, week 8 and week 12
Change in body mass index (BMI) kg/m^2
Changes in BMI (kg/m\^2) from baseline to week 12. Weight (kg) and height (m) will be measured and combined to report BMI in kg/m²
Baseline, week 4, week 8 and week 12
Change in waist circumference (cm)
Change in waist circumference (cm) from baseline to week 12
Baseline, week 4, week 8 and week 12
Change in hip circumference (cm)
Changes in hip circumference (cm) from baseline to week 12
Baseline, week 4, week 8 and week 12
Change in body fat mass (kg)
Change in body fat mass (kg) from baseline to week 12.
Baseline, week 4, week 8 and week 12
Change in body fat-free mass (kg)
Change in body fat-free mass (kg) from baseline to week 12.
Baseline, week 4, week 8 and week 12
Change in visceral fat rating
Change in visceral fat rating from baseline to week 12. Visceral Fat Rating from 1 to 12: Indicates a healthy level of visceral fat. Visceral Fat Rating from 13 to 59: Indicates an excess level of visceral fat.
Baseline, week 4, week 8 and week 12
Change in muscle mass (kg)
Change in muscle mass (kg) from baseline to week 12.
Baseline, week 4, week 8 and week 12
Secondary Outcomes (17)
Change in blood pressure (mmHg)
Baseline, week 4, week 8 and week 12
Change in total cholesterol (mg/dL)
Baseline and week 12
Change in low-density lipoprotein (LDL) (mg/dL)
baseline and week 12
Change in high-density lipoprotein (HDL) (mg/dL)
Baseline and week 12
Change in triglycerides (mg/dL)
Baseline and week 12
- +12 more secondary outcomes
Other Outcomes (11)
Physical activity level (MET-minutes/week)
Baseline and week 12
Change in Diet
Baseline, week 4 and week 12
Change in appetite
Baseline, week 4 and week 12
- +8 more other outcomes
Study Arms (2)
Soya-based dietary fibre beverage
EXPERIMENTALThe SBB beverage was in powdered form (1 sachet contain 53g of powder), and participants were instructed to prepare the liquid shake by mixing the 1 sachet of the powder with 250 mL of cold water in a shaker that had been provided. They were asked to consume two servings of the beverage at least 30 min before each breakfast and teatime every day for 12 weeks. The intervention group was given a sufficiently SBB sachet with a label indicating the ingredients and the preparation method. The breakfast, lunch, and dinner meals were recommended as normal meals (the meals that they habitually eat). The intervention involved the consumption of the SBB beverage powder while allowing participants to maintain their usual meal portions. There was no strict portion control, and participants could continue their habitual eating patterns. The focus was on incorporating the SBB beverage as part of their daily diet without restricting overall food intake.
Habitual diet
NO INTERVENTIONThe control group was asked to continue their usual breakfast, lunch, and dinner meals during the study period
Interventions
The intervention consume two servings of the beverage at least 30 min before each breakfast and teatime every day for 12 weeks. One serving is one sachet (53g) of beverage powder in 250 mL cold water. There was no strict portion control, and participants could continue their habitual eating patterns. The focus was on incorporating the SBB beverage as part of their daily diet without restricting overall food intake.
Eligibility Criteria
You may qualify if:
- Staff or students aged 18-50 years
- Participants with BMI 23-30 kg/m2
- Participants physically inactive
- Not having any allergies to any of the known food ingredients, especially milk and soy
- Not on lipid-lowering and oral hypoglycemic drugs
- No kidney diseases
You may not qualify if:
- Pregnant or lactating mothers
- Having known chronic disease conditions
- Having a known allergy history for soy and milk or any of the ingredients in the formula.
- History of any type of minor or major surgical procedure in the past 6 months.
- Currently on diet prescriptions or participating in regular physical activity sessions.
- On weight loss drugs or consuming dietary supplements such as protein shakes, whey protein, casein, fruit juices or fiber-based supplements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Campus, Universiti Sains Malaysia
Kubang Kerian, Kelantan, 16150, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wan Rosli Wan Ishak, PhD
School of Health Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dean of School of Health Sciences, USM Health Campus
Study Record Dates
First Submitted
May 15, 2026
First Posted
May 29, 2026
Study Start
June 30, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
May 29, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available to protect participant confidentiality and comply with institutional and ethical regulations governing clinical research data.